Treatment for some cancer patients has been delayed by up to a week because hospitals are running out of certain chemotherapy drugs.
Several hospitals have reported being left short over the last fortnight by pharmaceutical company Baxter Healthcare.
Baxter is the only firm supplying the compound drugs and has failed to deliver a full supply for Ireland.
In a statement to 98FM News the comapny has apologised:
"Baxter is currently experiencing a temporary supply constraint of compounded chemotherapy products supplied to a number of public and private hospitals in Ireland. We are doing all we can to restore production capacity as quickly as possible and minimise the impact to patients. We are working with other Baxter compounding units in the UK to identify if any extra capacity can be utilised.... We expect to resume production early next week. We would like to sincerely apologise to patients and clinicians for this situation"
Consultant Oncologist at St Vincent's Hospital, John Crown, says Baxter should be penalised for the error.
"Baxter is a really big international organisation and this cannot happen again. There should be a penalty clause built into their contract. I believe Baxter, has within their international empire, the ability (perhaps very expensively) to redeploy drugs and resources to move those drugs to other jurisdictions."